AtriCure, Inc. (ATRC) News
Latest headlines that mention ATRC, newest first · each headline opens the original publisher
- Last price
- $52.84
- Day change
- -0.88%
- Next earnings
- 2026-11-04
ATRC headlines
latest coveragePrivitera executed the sale under a pre-established Rule 10b5-1 trading plan.
The sale came at $38.42 per share, slightly below the day's market close, as AtriCure maintains its $2.0 billion market cap in the medical device sector.
Prange's open-market disposition reduced her direct holdings by 14%, though she retains over 22,800 shares in the $2.0 billion medical device company.
Also mentioned with ATRC
30dHeadlines that tag both tickers
ATRC news alerts
Get an alert by email or push when a new headline mentions ATRC.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.